CHEYENNE VISSARI: Open Payments
NPI 1720855315 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 15 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $168 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| SpringWorks Therapeutics, Inc. | 1 | $24 |
| Acrotech Biopharma Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| Cumberland Pharmaceuticals, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: ADSTILADRIN, ERLEADA, Polivy, VERZENIO, OGSIVEO, BELEODAQ, ULTOMIRIS, CALDOLOR.
Industry payments across PA — which companies pay providers there.
